The effects of 92 anthracycline compounds on the growth and DNA, RNA and protein synthesis of L1210 leukemia cells were studied in relationships to their structures and antitumor activity. The following structure-activity relationships were observed:
Since 1973, we have prepared about 100 anthracycline compounds; aclacinomycinsl-'', 2-hydroxyaclacinomycins5'0', 13-methylaclacinomycins7), 4-O-methylaclacinomycins',I), 6-O-methylaclacinomycin'), 4"'-aminoaclacinomycin10), 4"'-dehydrorhodomycin Y"), 11-hydroxyaclacinomycinsl1', 11-hydroxycinerubin All', rhodirubinsl'-), roseorubicins11 , baumycinsl'•1", 4-hydroxybaumycinst°', feudomycins1'), 1-hydroxydaunorubicinol'°t and trisarubicinoll0). We studied the effects of these various types of anthracyclines on the growth and macromolecular biosynthesis of cultured L1210 leukemia cells.
In this paper we report on the structure-activity relationships thus obtained.
Materials and Methods

L1210 Cell Growth in Culture
Mouse leukemia L1210 cells were cultured in RPMI 1640 "Nissui". Calf serum (1020%, Chiba Serum Institute, Chiba), sodium bicarbonate (0.125 %) and a mixture of penicillin (50 units/ml of medium) and streptomycin (50 ag/ml of medium) were added as supplements.
For the growth study, cells in the exponential phase (ca. 7 x 10° cells/ml) were diluted with fresh warm RPMI 1640 medium supplemented with 20 % calf serum to a cell density of approximately 4 ;:101 cells/ml. Nine tenth milliliter of the cell suspension was pipetted into each culture tube and 0.1 ml o a test compound was added to give the final concentration at 0.01 to 0.25 jig/ml. Compounds (anthra- Aclacinomycin A-oxime   RI   OH  OH  OH  OH  OHH  H  H   H   H  H   R4   COOCH3  COOCH3  COOCH3  COOCH3  COOCH3   COOCH3  COOCH,  COOCH,   COOCH3  COOCH3  COOCH3  COOCH,  COOCH3  COOCH3  COOCH3  COOCH3  COOCH3  COOCH3  COOCH3  COOCH3   H   H  COOCH,  COOCH3 COOCH, CH,COCH,  CH3  CH,  CH2CH3  CH2CH3  CH2CH3  CH2CH,  CH2CH,  CH2CH,.   CH2CH3   CH2CH3  CH2CH3  CH-CH,   CH-CH,   CH2CH,  CH-CH,   R6 RN cyclines) were dissolved in 0.02 M acetate buffer (pH 3.5) at a concentration of I mg/ml, and diluted to the desired concentration with phosphate buffered saline. In case of the hydrochloride salt, they were dissolved in distilled water instead of acetate buffer. Incubation was carried out at 37°C in a CO,-incubator and cell numbers were periodically determined using a hemocytometer over the course of 3 days by counting viable cells stained with 0.17% trypane blue. Cytotoxicity was expressed in 50 inhibitory concentration of the control growth on day 2 (IC., value). The average doubling time of L1210 leukemia cells was about 12 hours.
Incorporation of Labeled Thymidine, Uridine and Leucine into L1210 Leukemia Cells Cells in the logarithmic phase of growth were used. L1210 cells (5x 106 cells/ml) were incubated in RPMI 1640 medium containing 10% calf serum with gentle shaking at 37°C, preincubated with the anthracycline compound at a given concentration for 15 minutes, and thereafter 0.05 toCi/ml of [2-14C]-thymidine (58.0 mCi/mmole, New England Nuclear, Boston, Mass.), 0.05 ttCi/ml of [2-14C]uridine (52.4 mCi/mmole, New England Nuclear) or 0.1 /LCi/ml of L-[1°C-(U)]leucine (355.0 mCi/mmole, New England Nuclear) was added. After incubation for 60 minutes, I ml of cold TCA (10 %) was added to 1 ml of the reaction mixture. The precipitate was collected by centrifugation at 2,000 r.p.m. for 10 minutes, washed twice with 2 ml of ice-cold 5 % TCA and dissolved in 0.25 ml of 95 % formic acid. The radioactivity was measured in 10 ml of BRAY'S cocktail by an Aloka LSC-653 liquid scintillation spectrometer. All experiments were done in duplicate.
Inhibitory effects were expressed in IC,, values which were obtained by plotting logarithmic anthracycline concentrations against probit percentage of the incorporation of radioactive precursors into the acid-insoluble fraction.
Anthracycline Compounds
The following 92 compounds were tested and their structure and molecular weight are listed in Tables I -5 and Fig. 1 . Aclacinomycins, 2-hydroxyaclacinomycins, 13-methylaclacinomycins, rhodirubins, baumycins, 4-hydroxybaumycins, feudomycins and roseorubicins were prepared from the cultured broths of Streptomyces galilaeus MA144-M1, S. coeruleorubidus ME130-A4, S. sp. ME 505, Actinomyces roseoviolaceus A529, Actinomadura sp. D326 and their mutant strains according to the purification procedures described previously'.-16) Various anthracycline trisaccharides having cinerulosyl-2-deoxyfucosyl-rhodosaminyl moiety were prepared by either microbial or chemical glycosidation°,11.'s,20> Hydrochloride salts of adriamycin and daunomycin, 4-demethoxyadriamycin and 4-demethoxydaunomycin were provided by Dr. F. F. ARCAMONE, Farmitalia C. Erba, Milan; R-rhodomycin I hydrochloride was given by Dr. W. IHN, Central Institute of Microbiology and Experimental Therapy, Jena; sulfurmy- which was modified at the C-9 of DM, was almost the same as that of DM, but FM-B (acetonyl at C-9) and FM-D (methyl at C-9) were less cytotoxic. Baumycins (BM) Al and A2 and 4-hydroxybaumycin A1, which has an unique residue at C-4' of DM, were significantly more cytotoxic than DM and carminomycin I (CM).
Among nogalamycin (NLM) analogs, NLM was the most cytotoxic followed by 7-con-O-methylnogarol (7-OMEN) and nogarnycin (NM).
Inhibitory Effects on Macromolecular Synthesis
The effects on DNA and RNA synthesis in cultured L1210 leukemia cells were expressed in IC50 values (nht) which were obtained by plotting the logarithmic compound concentrations against probit percentage of inhibition on nucleic acid synthesis, as illustrated in Fig. 2 . On the other hand, the effects in inhibiting protein synthesis were expressed in inhibition percentage of the incorporation of 14C-leucine at a concentration of 10 jig/ml. As shown in Tables 
Discussion
We have found first that ACM and its related oligosaccharides inhibit RNA synthesis to a greater degree than DNA synthesis',"). This is one characteristic of this class of anthracyclines. Subsequently, CROOKE et al.22> have studied and confirmed that anthracycline glycosides may be divided into two classes on the basis of their effects on DNA and RNA synthesis. Class I anthracyclines, i.e. AM, DM, PM etc. inhibited DNA, whole cellular RNA and nucleolar RNA synthesis at approximately comparable concentrations. Class II anthracyclines, i.e. ACM and related oligosaccharides inhibited whole cellular RNA synthesis at 6 to 7-fold lower concentrations than those required to inhibit DNA synthesis, and nucleolar RNA synthesis was inhibited to an even greater degree than whole cell RNA synthesis (170 to 1250-fold lower). BACHUR et a1. 25 and DASKAL et a1.24) also reported that there were major differences in the intracellular disposition of class I and II anthracyclines and in the rate and extent of nucleolar ultrastructural aberration caused by them. ACM located primarily in the cytoplasm, whereas DM was found almost exclusively in nucleus.
We compared the inhibitory effects of 92 compounds on the growth and nucleic acid and protein syntheses of L1210 leukemia cells. For comparison, the ratios of the concentrations necessary to inhibit by 50%, (IC,, nM) of whole cell DNA and RNA synthesis are listed in Tables 1 ' 5 . The effects of anthracyc]ines on nucleic acid synthesis were classified into three types when the concentrations required for 50% inhibition of DNA and RNA were plotted as shown in Fig. 3 . IC,, values of group I anthracyclines (monosaccharides) such as DM, AM, CM, aklavin inhibited DNA and RNA synthesis at approximately an equal concentration (IC,, ratios of 1 -4), while ICs, values of group II anthracyclines such as aclacinomycins, cinerubins and related trisaccharides to inhibit RNA synthesis was one-tenth that of DNA synthesis (IC,, ratios were over 7). The third group included mainly disaccharides, showing IC,, ratios of 5 -6. The correlation coefficients (r) between IC,, for DNA synthesis and that for RNA synthesis were as follows: overall, 0.79; in group I, 0.87; in group II, 0.89; in group III, 0.99. From the results based on the cytotoxicity and inhibitory effects on macromolecular synthesis in cultured L1210 leukemia cells, structure-activity relationship of anthracycline glycosides can be discerned both in respect of the number and types of sugar moieties and in respect of the substitution pattern in the aglycone portion of the molecules.
With respect to the AKN-, 13-methyl AKN-, 2-hydroxy AKN-, 4-0-methyl AKN-, PMN-and DMNglycosides and roseorubicins, there was a gradual increase in cytotoxicity when the oligosaccharide chain length was increased from one to five sugar residues. This was reflected in the ratios for the IC" values of DNA and RNA synthesis. Monosaccharides having only rhodosamine (aklavin, 13-methylaklavin, 2-hydroxyaklavin, 4-O-methylaklavin and PM) behaved as did AM, DM and CM (representative of group I anthracycline) in respect to their IC50 ratios (about 1 -4) on DNA and RNA synthesis. In this connection, disaccharides (MA144 Sl, 4-0-methyl S1, 2-hydroxy S1, musettamycin, collinemycin and roseorubicin B) having 2-deoxyfucosyl-rhodosaminide or rhodosaminyl-rhodosaminide moiety were between groups I and II in respect to their IC,, ratios (5-6).
On the other hand, 4'-substituted derivatives of group I anthracyclines, 4'-O-tetrahydropyranyladriamycin and 4'-O-tetrahydropyranyldaunomycin~'), BM Al and A2, 4-hydroxy BM Al and A2 and 4-hydroxybaumycinol Al and A2 were more cytotoxic than the corresponding parent compounds, but 4'-substituted moieties had no influence on the IC,, ratio for DNA and RNA synthesis, having the ratio of 1 -2, similar to the group I anthracyclines. However, when dihydrocarminomycinone and daunomycinone were glycosidated with the trisaccharide moiety of cinerulosyl-2-deoxyfucosyl-rhodosaminide by microbial and chemical processes, the resulting anthracycline trisaccharides (trisarubicinol and DMN-A) showed the characters of group II anthracyclines in respect to their ICS, ratios (6.8 -10) and a markedly increased potency against cell growth and nucleic acid synthesis.
Except for the nogalamycins and steffimycins, all of the pctent anthracyclines have rhodosamine, Nmonomethyldaunosamine or daunosamine as the first sugar. MA144 U5 was an inactive analog of ACM having only a neutral sugar; 2-deoxyfucose in place of rhodosamine. Thus, it was suggested that the amino sugar was necessary for activity. Nogalamycins which did not possess an amino sugar, but had a N,N-dimethylamino function in their aglycone moiety, were active as shown in Table 5 . ACM having a N,N-dimethyl group on its amino sugar was more potent than its N-monodemethyl and N,Ndidemethyl analogs (MA144 Ll and K1). A similar relationship was observed between the following compounds; marcellomycin and alcindoromycin, AM with NN-dimethyl AM, DM and N,N-dimethyl DM. It has been reported that the N,N-dimethylamino function in anthracyclines is related to their mutagenicity20'°'°. ACM, cinerubin A, rhodirubin B, NLM and steffimycin were not mutagenic, while DM, AM and BM were highly mutagenic in the AMES' and rec-tests. Furthermore, it has been found by UMEZAWA et al.2B° that N-demethylation of ACM correlates with its mutagenic activity, and the Nmethyl derivatives of AM and DM are devoid of mutagenicity. These effects suggests that the modification of the amino group may change the modes of the binding or the intercalation of the aglycone moiety to DNA.
Substitutions of the terminal sugar in ACM by aculose, which is an a,(3-unsaturated hexulose, and 4-aminohexose resulted in increased activity in inhibiting nucleic acid synthesis, but not in antitumor activity in vivo (Table 6) .
Anthracycline oligosaccharides possessing a cinerulosyl-2-deoxyfucosyl-rhodosaminide moiety were prepared from the fermentation broth of several Streptomvices, by microbial glycosidation using a mutant strain KE303 of S. galilaeus MA144-M15.11, or by chemical modification8'0). The position of the hydroxyl group on the aromatic ring of these trisaccharides influenced the degree of cytotoxicity and the inhibitory effect on macromolecular biosynthesis. a2-RMN-A which has hydroxyl groups at C-1, C-4 and C-11 was less potent than ACM with the hydroxyl at C-4 and C-6, suggesting that the hydroxyl group at C-6 had an important role for potency. Cinerubin A, s-RMN-A and e-isoRMN-A which have hydroxyl groups at C-1 and/or C-11 of ACM, and also at C-6 were more potent in their cytotoxicity and inhibitory effects on RNA and DNA synthesis, and they have a strong toxicity in vivo",20> as shown in Table 6 . 2-Hydroxy ACM had marked antitumor activity in vivo, in spite of its relatively low potency in vitro. Derivatives of ACM such as 4-0-methyl ACM and 6-0-methyl ACM were 2-5-fold lower in potency than ACM in the in vitro system. Among these oligosaccharides, the replacement of ethyl at C-9 of ACM with a methyl group as in auramycin A resulted about a 50 % decrease of potency in vitro. 13-Methyl ACM which has the isopropyl group on C-9 and sulfurmycin A having the acetonyl group on C-9 showed almost the same potency as ACM. This suggests that there may be an optimum length of C-9 side chain for potency. The removal of the 10-carbomethoxy group from ACM resulted in a marked reduction (1/10) of the activity which inhibits RNA synthesis and a 20 5-fold reduction in the cytotoxicity and DNA inhibitory actions. The replacement of the 10-carbomethoxy group with the hydroxyl group (g-RMN-A) produced a high antitumor activity in vivo (T/C: 200%) at a broad range of doses (2 -6 mg/kg/day), but its inhibitory potency on RNA synthesis was lowered to one-tenth of ACM (the IC,, ratio of 3.7). Thus, it is suggested that the 10-carbomethoxy group closely correlates with the inhibition of RNA synthesis. DUVERNAY et a1. 30 ' have reported that the removal of the 10-carbomethoxy from marcellomycin and rudolfomycin caused reduction in in vitro and in vivo activity and the 10-carbomethoxy in the class II anthracycline was essential for inhibition of nucleolar RNA synthesis. As shown in Tables I and 3 , 10-epi-ACM and y-RMN-A with glycosidation at C-10 were far less potent, indicating that the group and the configuration at C-10 of anthracyclinone greatly affect the activity.
Comparative studies on the cytotoxicity and inhibitory effect on nucleic acid synthesis of 4-demethoxy derivatives of DM and AM with their 4-demethoxy-l l-deoxy derivatives3l> showed that the hydroxyl group at C-11 was effective in increasing the potency. In DM analogs having various side chains at C-9 such as methyl, ethyl, acetyl, acetonyl, hydroxyacetyl and 1-hydroxyethyl, there were no correlations between these groups and in vitro potency. With respect to the correlation between the in vitro and in vivo activity against L1210, there was almost no correlation (r=0.58).
The correlation between IC,, values of cytotoxicity and nucleic acid synthesis was as follows: r=0.73 between cytotoxicity and DNA synthesis inhibition; r=0.66 between cytotoxicity and RNA synthesis inhibition.
In the course of counting the viable cells under the microscope, giant cells were observed in the cultures treated with AM, DM, CM and their analogs, PM, f3-rhodomycin I, /3-RMN-A and 7-OMEN belonging to group I anthracycline. 
